{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:21:17Z","timestamp":1783693277390,"version":"3.55.0"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal University of Pampa and the Coordination for the Improvement of Higher Education Personnel - CAPES","award":["88881.506652\/2020-01"],"award-info":[{"award-number":["88881.506652\/2020-01"]}]},{"name":"Federal University of Pampa and the Coordination for the Improvement of Higher Education Personnel - CAPES","award":["19\/2551-0001970-0"],"award-info":[{"award-number":["19\/2551-0001970-0"]}]},{"name":"Federal University of Pampa and the Coordination for the Improvement of Higher Education Personnel - CAPES","award":["309401\/2020-8"],"award-info":[{"award-number":["309401\/2020-8"]}]},{"name":"Rio Grande do Sul State Research Support Foundation - FAPERGS","award":["88881.506652\/2020-01"],"award-info":[{"award-number":["88881.506652\/2020-01"]}]},{"name":"Rio Grande do Sul State Research Support Foundation - FAPERGS","award":["19\/2551-0001970-0"],"award-info":[{"award-number":["19\/2551-0001970-0"]}]},{"name":"Rio Grande do Sul State Research Support Foundation - FAPERGS","award":["309401\/2020-8"],"award-info":[{"award-number":["309401\/2020-8"]}]},{"name":"National Council for Scientific and Technological Development - CNPq","award":["88881.506652\/2020-01"],"award-info":[{"award-number":["88881.506652\/2020-01"]}]},{"name":"National Council for Scientific and Technological Development - CNPq","award":["19\/2551-0001970-0"],"award-info":[{"award-number":["19\/2551-0001970-0"]}]},{"name":"National Council for Scientific and Technological Development - CNPq","award":["309401\/2020-8"],"award-info":[{"award-number":["309401\/2020-8"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>The combination of drugs for malaria treatment holds promise, although the potential for drug-drug interactions remains insufficiently explored in novel therapeutic combinations. This study aims to assess these interactions using physiologically based pharmacokinetic modeling, supported by data-driven parameter optimization, as a step towards the preclinical development of a formulation containing chloroquine and colchicine. Given that both compounds share metabolic pathways involving CYP3A4 and CYP2D6, we developed individual and population models using a middle-out strategy in PK-Sim\u00ae, an open-source software, and validated these models by comparing predicted and observed pharmacokinetic parameters. Simulations evaluated competitive inhibition between the compounds. The results indicated no significant changes in systemic exposure, with the area under the curve and maximum concentration values remaining consistent between single and combined administration. Our findings suggest that the proposed modeling is a powerful tool for predicting pharmacokinetic interactions during the preformulation stage, offering mechanistic insight and supporting rational decision-making prior to in vivo studies. The absence of significant drug-drug interactions between chloroquine and colchicine reinforces the feasibility of advancing this combination in future therapeutic development.<\/jats:p>","DOI":"10.1590\/1414-431x2026e15326","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:11:40Z","timestamp":1783692700000},"source":"Crossref","is-referenced-by-count":0,"title":["A clinical drug-drug interaction assessment using physiologically based pharmacokinetic modeling: a case study with chloroquine and colchicine"],"prefix":"10.1590","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-982X","authenticated-orcid":false,"given":"T.R.","family":"Maciel","sequence":"first","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil; Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-0700","authenticated-orcid":false,"given":"F.E.G.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2611-0461","authenticated-orcid":false,"given":"I.C.","family":"Bitencourt","sequence":"additional","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-4952","authenticated-orcid":false,"given":"C.O.","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil; Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-6736","authenticated-orcid":false,"given":"S.E.","family":"Haas","sequence":"additional","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil; Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"100021","DOI":"10.1124\/dmd.123.001384","article-title":"Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions","volume":"53","author":"Foti RS","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.1013","article-title":"Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective","volume":"104","author":"Shebley M","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"ref3","series-title":"World Malaria Report 2024","year":"2024"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/molecules24193601","article-title":"Combination therapy strategies for the treatment of malaria","volume":"24","author":"Alven S","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/1061186X.2017.1291645","article-title":"Malaria treatment using novel nano-based drug delivery systems","volume":"25","author":"Baruah UK","year":"2017","journal-title":"J Drug Target"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12936-023-04763-4","article-title":"Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam","volume":"22","author":"Cao VAT","year":"2023","journal-title":"Malaria J"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jcph.2073","article-title":"Drug-drug interactions of artemisinin-based combination therapies in malaria treatment: a narrative review of the literature","volume":"62","author":"Maldonado JH","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"e0134522","DOI":"10.1128\/aac.01345-22","article-title":"Integrating pharmacokinetic-pharmacodynamic modeling and physiologically based pharmacokinetic modeling to optimize human dose predictions for plasmodium falciparum malaria: a chloroquine case study","volume":"67","author":"Redhi D","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.xphs.2018.10.056","article-title":"Dose optimization of chloroquine by pharmacokinetic modeling during pregnancy for the treatment of Zika virus infection","volume":"108","author":"Olafuyi O","year":"2019","journal-title":"J Pharm Sci"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/pharmaceutics12090846","article-title":"Mechanisms of CYP450 inhibition: understanding drug-drug interactions due to mechanism-based inhibition in clinical practice","volume":"12","author":"Deodhar M","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"105462","DOI":"10.1016\/j.jddst.2024.105462","article-title":"Co-encapsulation of chloroquine plus colchicine in cationic nanocapsule suspensions: technological development and toxicological evaluation","volume":"93","author":"Maciel TR","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.apsb.2020.04.007","article-title":"Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model","volume":"10","author":"Cui C","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"15","key":"ref13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003088-200342150-00004","article-title":"Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs","volume":"42","author":"Brocks DR","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub RA","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/futurepharmacol2020011","article-title":"Pharmacogenetic perspective for optimal gout management","volume":"2","author":"Alrajeh KY","year":"2022","journal-title":"Future Pharmacol"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.apsb.2016.04.004","article-title":"PBPK modeling and simulation in drug research and development","volume":"6","author":"Zhuang X","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bcp.12234","article-title":"Combining the \u2018bottom up\u2019 and \u2018top down\u2019 approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data","volume":"79","author":"Tsamandouras N","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","article-title":"Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses","volume":"36","author":"Ferron GM","year":"1996","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","article-title":"Disposition of chloroquine in man after single intravenous and oral doses","volume":"15","author":"Gustafsson LL","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/096032719201100210","article-title":"Prevention of chloroquine absorption by activated charcoal","volume":"11","author":"Neuvonen PJ","year":"1992","journal-title":"Human Exp Toxicol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/AAC.02794-13","article-title":"Pharmacokinetic interactions between primaquine and chloroquine","volume":"58","author":"Pukrittayakamee S","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00609430","article-title":"Zero-order absorption and linear disposition of oral colchicine in healthy volunteers","volume":"37","author":"Thomas G","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.1987.tb03048.x","article-title":"The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses","volume":"23","author":"Walker O","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"ref24"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.111.043174","article-title":"Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling","volume":"40","author":"Meyer M","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10928-020-09684-2","article-title":"Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy","volume":"47","author":"Maharaj AR","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/pharmaceutics13101734","article-title":"A novel method for predicting the human inherent clearance and its application in the study of the pharmacokinetics and drug-drug interaction between azidothymidine and fluconazole mediated by UGT enzyme","volume":"13","author":"Yuan Y","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref28","series-title":"ICH M12 Guideline on Drug Interaction Studies","author":"European Medicines A","year":"2023"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/metabo11020075","article-title":"Evaluation of pharmacokinetic drug-drug interactions: a review of the mechanisms, in vitro and in silico approaches","volume":"11","author":"Peng Y","year":"2021","journal-title":"Metabolites"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1988.tb03332.x","article-title":"Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria","volume":"25","author":"Edwards G","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"ref31","article-title":"Clinical drug interaction studies \u2014 cytochrome P450 enzyme- and transporter-mediated drug interactions","year":"2020","journal-title":"Guidance for Industry"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40360-018-0221-6","article-title":"Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients","volume":"19","author":"Molanaei H","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics","volume":"85","author":"Morgan ET","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.1.4.629","article-title":"Regulation of drug metabolism and disposition during inflammation and infection","volume":"1","author":"Renton KW","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis C","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"38","key":"ref36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5897\/AJPP2017.4828","article-title":"A review of clinical pharmacokinetics of chloroquine and primaquine and their application in malaria treatment in Thai population","volume":"11","author":"Kodchakorn C","year":"2017","journal-title":"Afr J Pharm Pharmacol"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jcph.1951","article-title":"Physiologically based pharmacokinetic modeling to assess the impact of CYP2D6-mediated drug-drug interactions on tramadol and O-Desmethyltramadol exposures via allosteric and competitive inhibition","volume":"62","author":"Long T","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/dmd.31.6.748","article-title":"In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation","volume":"31","author":"Projean D","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger UM","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref40","year":"2024"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2026000103849&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:11:46Z","timestamp":1783692706000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2026000103849&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"alternative-id":["S0100-879X2026000103849"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2026e15326","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e15326"}}